Format

Send to

Choose Destination
See comment in PubMed Commons below
Haematologica. 2011 Jun;96(6):820-8. doi: 10.3324/haematol.2010.031179. Epub 2011 Feb 28.

Up-regulation of homeodomain genes, DLX1 and DLX2, by FLT3 signaling.

Author information

1
Division of Hematology-Oncology, Medical University of South Carolina, Charleston, SC, USA. julia.starkova@lfmotol.cuni.cz

Abstract

BACKGROUND:

Activating mutations in fms-like tyrosine kinase-3 (FLT3) are frequent in acute myeloid leukemia and represent both a poor prognostic feature and a therapeutic target. We have identified a previously unrecognized downstream effect of FLT3 activation, namely up-regulation of the homeodomain genes, DLX1 and DLX2.

DESIGN AND METHODS:

MV4;11 cells with FLT3-internal tandem duplication mutation, RS4;11 cells with wild-type FLT3 and blasts from patients with acute myeloid leukemia were used to pursue the relation between FLT3, DLX1/2 and transforming growth factor-β (TGFβ). Real-time quantitative reverse transcriptase polymerase chain reaction, western blot and reverse-phase protein array were performed to detect changes in gene and protein expression. RNA interference and MTS assays were used to study the interaction of PKC412, FLT3 inhibitor and TGFβ1.

RESULTS:

A direct relationship between FLT3 activity and DLX1/2 expression was revealed by both inhibition and up-regulation of FLT3 signaling in MV4;11 and RS4;11 cell lines, respectively, in isolated blast cells from patients with acute myeloid leukemia, and in reverse-phase protein array assays of samples from patients with acute myeloid leukemia. Mechanistically, the link between FLT3 and DLX1 expression appears to involve MAPK signaling through the ERK and JNK pathways. To determine whether elevated DLX1 had a functional consequence, we explored the reported inhibition by DLX1 on TGFβ/Smad signaling. Indeed, TGFβ responses were blunted by FLT3 activation in a DLX1-dependent manner and FLT3 inhibition resulted in a time-dependent increase in nuclear phospho-Smad2.

CONCLUSIONS:

These findings suggest that alterations in DLX1/2 contribute to the biological consequences of FLT3 activation.

PMID:
21357706
PMCID:
PMC3105643
DOI:
10.3324/haematol.2010.031179
[Indexed for MEDLINE]
Free PMC Article
PubMed Commons home

PubMed Commons

0 comments
How to join PubMed Commons

    Supplemental Content

    Full text links

    Icon for HighWire Icon for PubMed Central
    Loading ...
    Support Center